ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in vitro systems and easing novel compounds’ preclinical development.
Pharmacology 2020 Event
Recent Posts
- The evaluation of drug interactions in preclinical stages optimizes novel drug development
- Role of pharmacological efflux receptors in cancer treatment resistance
- Recommended cell-based in vitro testing to assess BCRP protein-mediated transport
- 3rd SCI-RSC Symposium on Transporters in Drug Discovery and Development
- Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?